Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jaguar Animal Health Other Long-Term Assets 2014-2024 | JAGX

Jaguar Animal Health other long-term assets from 2014 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  
Jaguar Animal Health Annual Other Long-Term Assets
(Millions of US $)
2024 $1
2023 $1
2022 $1
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $3
2014 $0
2013 $0
Jaguar Animal Health Quarterly Other Long-Term Assets
(Millions of US $)
2024-12-31 $1
2024-09-30 $1
2024-06-30 $0
2024-03-31 $0
2023-12-31 $1
2023-09-30 $1
2023-06-30 $1
2023-03-31 $1
2022-12-31 $1
2022-09-30 $2
2022-06-30 $2
2022-03-31 $0
2021-12-31 $0
2021-09-30
2021-06-30
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $1
2018-06-30 $0
2018-03-31
2017-12-31
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $1
2016-03-31 $3
2015-12-31 $3
2015-09-30 $5
2015-06-30 $0
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.012B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $96.855B 36.33
Zoetis (ZTS) United States $69.448B 25.91
Daiichi Sankyo, - (DSNKY) Japan $48.042B 24.44
Takeda Pharmaceutical (TAK) Japan $47.919B 10.61
Sandoz Group AG (SDZNY) Switzerland $19.518B 0.00
Summit Therapeutics (SMMT) United States $18.039B 0.00
Merck (MKKGY) Germany $17.790B 14.72
Shionogi (SGIOY) Japan $13.871B 13.90
United Therapeutics (UTHR) United States $13.844B 12.25
Neurocrine Biosciences (NBIX) United States $12.035B 41.22
IPSEN (IPSEY) France $10.376B 0.00
Orion OYJ (ORINY) Finland $9.160B 24.77
Corcept Therapeutics (CORT) United States $7.472B 60.74
Madrigal Pharmaceuticals (MDGL) United States $6.635B 0.00
Stevanato Group S.p.A (STVN) Italy $6.602B 41.92
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.263B 0.00
Grifols, S.A (GRFS) Spain $5.033B 0.00
Soleno Therapeutics (SLNO) United States $3.726B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.939B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.861B 10.03
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.238B 12.24
BioCryst Pharmaceuticals (BCRX) United States $2.109B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.078B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.684B 0.00
Guardian Pharmacy Services (GRDN) United States $1.635B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.613B 0.00
Indivior (INDV) United States $1.583B 6.71
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Ocular Therapeutix (OCUL) United States $1.123B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.915B 0.00
Harrow (HROW) United States $0.902B 0.00
Enliven Therapeutics (ELVN) United States $0.896B 0.00
Ardelyx (ARDX) United States $0.885B 0.00
Collegium Pharmaceutical (COLL) United States $0.869B 4.62
AleAnna (ANNA) United States $0.716B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.701B 0.00
Organogenesis (ORGO) United States $0.657B 0.00
Akebia Therapeutics (AKBA) United States $0.644B 0.00
KalVista Pharmaceuticals (KALV) United States $0.609B 0.00
Xencor (XNCR) United States $0.568B 0.00
Bioventus (BVS) United States $0.540B 13.73
Savara (SVRA) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.529B 11.49
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.500B 0.00
Elite Pharmaceuticals (ELTP) United States $0.448B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.434B 0.00
Altimmune (ALT) United States $0.413B 0.00
Zevra Therapeutics (ZVRA) United States $0.411B 0.00
CytoDyn (CYDY) United States $0.401B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Verve Therapeutics (VERV) United States $0.376B 0.00
Siga Technologies (SIGA) United States $0.375B 6.40
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Heron Therapeutics (HRTX) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 8.92
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Avita Medical (RCEL) United States $0.250B 0.00
Nature's Sunshine Products (NATR) United States $0.243B 22.46
Wellgistics Health (WGRX) United States $0.224B 0.00
MediWound (MDWD) Israel $0.193B 0.00
ProKidney (PROK) United States $0.187B 0.00
OmniAb (OABI) United States $0.187B 0.00
Esperion Therapeutics (ESPR) United States $0.173B 0.00
Journey Medical (DERM) United States $0.161B 0.00
Nanobiotix S.A (NBTX) France $0.156B 0.00
Profound Medical (PROF) Canada $0.145B 0.00
4D Molecular Therapeutics (FDMT) United States $0.144B 0.00
Larimar Therapeutics (LRMR) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Aclaris Therapeutics (ACRS) United States $0.135B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Lyell Immunopharma (LYEL) United States $0.124B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.123B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Aldeyra Therapeutics (ALDX) United States $0.120B 0.00
Nektar Therapeutics (NKTR) United States $0.113B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Lexeo Therapeutics (LXEO) United States $0.099B 0.00
Galectin Therapeutics (GALT) United States $0.099B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.089B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Achieve Life Sciences (ACHV) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 13.20
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 49.11
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.034B 0.00
Prelude Therapeutics (PRLD) United States $0.033B 0.00
FibroGen (FGEN) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Surrozen (SRZN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
DURECT (DRRX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.42
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.22
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00